WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 62
GDP / capita (US$): 53'3481 Child (under 5 years) mortality rate: 72

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 412  407  401  394  388  332  257  193 
Births
Surviving infants
Pop. less than 5 years 33  34  35  36  37  34  34  29 
Pop. less than 15 years 106  106  107  107  107  101  89  74 
Female 15-49 years 116  115  114  113  112  99  68  46 

Number of reported case

(Click for retrospective incidence data for Brunei Darussalam)
Diphtheria
Japanese encephalitis
Measles 42  12  485 
Mumps 14  19  12  41  33 
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Brunei Darussalam)
Vaccine year result method % card seen                                                
BCG          100  96  95  100  100  100  95 
DTP1          99*  96  98  96  97  99 
DTP3          90  97  95  99  98  99  100  89 
HepB_BD          95  95  96  100  100  100 
HepB3          100  93  96  99*  96  100  96 
Hib3          90  97  99  99  98 
JapEnc         
MCV          99  91  94  99  100  99  73 
MCV2          96  93  93  99  89 
PCV1         
PCV3         
Pol3          90  99*  99  99  99*  99  100  89 
Rota1         
Rota_last         
Rubella1          99  91  94  100 
TT2plus          56  78  76  75  75  72 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Brunei Darussalam)
BCG 99  96  95  99  99  99  91  99 
DTP1 96  99  98  99  99  99  97  96 
DTP3 90  97  95  99  98  99  93  89 
HepB3 99  93  96  96  96  99  96 
Hib3 90  97  95  99  98 
MCV 99  91  94  99  99  99  99  73 
PAB 95  95  95  65  65  77  40 
PCV3
Pol3 90  95  99  99  97  99  92  89 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibHepIPV 2, 4, 6 months; Yes
DTaPIPV 5 years; Yes
HIB 1 year; Yes
HPV 12-13 years; +1, +6 months;
HepB birth; Yes
MMR 1, 3 years; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  No  No  No  No     
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number        

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number    
Nº districts with DTP3 coverage >=80% number        
% of districts with DTP3 coverage >=80% From 0 to 100%     100  100  100     
Nº districts with measles (MCV1) coverage >=95% number        
% of districts with MCV1 coverage >=95% From 0 to 100%     100  100  100     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR No  No  No  No       
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%       100       

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.